DACLATAVIR
Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug DaclatavirThere might be more companies who might join the patent pool for the drug. Daclatasvir is known to cure multiple genotypes of the Hep C vir...
- Load More